Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related morbidity and mortality despite therapeutic advances. Current treatments offer limited benefit to many patients, a limitation closely linked to distinctive features of the tumor micro... ...

请注册登录后继续浏览